Marcy l’Étoile, France, June 16, 2020 (AFP) – French President Emmanuel Macron announced Tuesday a series of measures to boost medical research, development and production on home soil to avoid the country’s dependence on foreign suppliers in future health crises.
Paris, May 25, 2020 (AFP) – French pharmaceutical giant Sanofi on Monday said it planned to divest its stake in US biotech firm Regeneron which is valued at around $13 billion.
Washington, May 18, 2020 (AFP) – Injecting people with a new, experimental drug every eight weeks provides better protection against HIV than daily pills that have revolutionized the fight against AIDS, US government researchers reported Monday.
Washington, May 18, 2020 (AFP) – The higher summer temperatures in the Northern Hemisphere are unlikely to significantly limit the growth of the coronavirus pandemic, according to a Princeton University study published Monday in the journal Science.
Washington, May 15, 2020 (AFP) – A specially formulated antimicrobial coating can keep surfaces clear of a human coronavirus for up to 90 days with just one application, a preliminary study said Friday, suggesting a new line of defense against COVID-19.
Geneva, May 13, 2020 (AFP) – The new coronavirus may never go away and populations around the world will have to learn to live with it, the World Health Organization warned Wednesday.
The Hague, May 14, 2020 (AFP) – A vaccine for the coronavirus could be ready in a year’s time under an “optimistic” scenario, based on data from trials that are under way, the European Medicines Agency said Thursday.
Geneva, April 22, 2020 (AFP) – COVID-19 will stalk the planet for a long time to come, the World Health Organization said Wednesday, warning that most countries were still in the early stages of tackling the pandemic.
Paris, April 19, 2020 (AFP) – More than 30 studies are under way in France — of a world total of 860 — in search of drugs to treat the COVID-19 disease sweeping the world, infectologist Florence Ader said Sunday.
Brussels, April 22, 2020 (AFP) – The European Commission on Wednesday authorised a merger of US drug giant Pfizer’s off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
